89 related articles for article (PubMed ID: 22098721)
1. NOD2 gene variants and spontaneous bacterial peritonitis.
Filik L
Liver Int; 2012 Mar; 32(3):521; author reply 521-2. PubMed ID: 22098721
[No Abstract] [Full Text] [Related]
2. NOD2 gene variants are a risk factor for culture-positive spontaneous bacterial peritonitis and monomicrobial bacterascites in cirrhosis.
Bruns T; Peter J; Reuken PA; Grabe DH; Schuldes SR; Brenmoehl J; Schölmerich J; Wiest R; Stallmach A
Liver Int; 2012 Feb; 32(2):223-30. PubMed ID: 21745302
[TBL] [Abstract][Full Text] [Related]
3. Susceptibility to spontaneous bacterial peritonitis--are genetics the future?
Appenrodt B; Sauerbruch T
Liver Int; 2012 Feb; 32(2):177-8. PubMed ID: 22226231
[No Abstract] [Full Text] [Related]
4. Toll-like receptor (TLR) 2 promoter and intron 2 polymorphisms are associated with increased risk for spontaneous bacterial peritonitis in liver cirrhosis.
Nischalke HD; Berger C; Aldenhoff K; Thyssen L; Gentemann M; Grünhage F; Lammert F; Nattermann J; Sauerbruch T; Spengler U; Appenrodt B
J Hepatol; 2011 Nov; 55(5):1010-6. PubMed ID: 21356257
[TBL] [Abstract][Full Text] [Related]
5. Further evidence for the relevance of TLR2 gene variants in spontaneous bacterial peritonitis.
Bruns T; Reuken PA; Fischer J; Berg T; Stallmach A
J Hepatol; 2012 May; 56(5):1207-1208. PubMed ID: 22019578
[No Abstract] [Full Text] [Related]
6. Nucleotide-Binding Oligomerization Domain-Containing Protein 2 Variants in Patients with Spontaneous Bacterial Peritonitis.
Harputluoglu MM; Dertli R; Otlu B; Demirel U; Yener O; Bilgic Y; Erdogan MA; Atayan Y; Cagin YF
Dig Dis Sci; 2016 Jun; 61(6):1545-52. PubMed ID: 26725065
[TBL] [Abstract][Full Text] [Related]
7. Nucleotide-binding oligomerization domain containing 2 (NOD2) variants are genetic risk factors for death and spontaneous bacterial peritonitis in liver cirrhosis.
Appenrodt B; Grünhage F; Gentemann MG; Thyssen L; Sauerbruch T; Lammert F
Hepatology; 2010 Apr; 51(4):1327-33. PubMed ID: 20087966
[TBL] [Abstract][Full Text] [Related]
8. Common NOD2 Risk Variants as Major Susceptibility Factors for Bacterial Infections in Compensated Cirrhosis.
Reichert MC; Ripoll C; Casper M; Greinert R; Vandieken E; Grünhage F; Appenrodt B; Zipprich A; Lammert F
Clin Transl Gastroenterol; 2019 Jan; 10(1):e00002. PubMed ID: 30702490
[TBL] [Abstract][Full Text] [Related]
9. A variant in the nuclear dot protein 52kDa gene increases the risk for spontaneous bacterial peritonitis in patients with alcoholic liver cirrhosis.
Lutz P; Krämer B; Kaczmarek DJ; Hübner MP; Langhans B; Appenrodt B; Lammert F; Nattermann J; Hoerauf A; Strassburg CP; Spengler U; Nischalke HD
Dig Liver Dis; 2016 Jan; 48(1):62-8. PubMed ID: 26493630
[TBL] [Abstract][Full Text] [Related]
10. Recipient's genetic R702W NOD2 variant is associated with an increased risk of bacterial infections after orthotopic liver transplantation.
Janse M; de Rooij BJ; van Hoek B; van den Berg AP; Porte RJ; Blokzijl H; Coenraad MJ; Hepkema BG; Schaapherder AF; Ringers J; Weersma RK; Verspaget HW
PLoS One; 2013; 8(8):e72617. PubMed ID: 23977330
[TBL] [Abstract][Full Text] [Related]
11. A farnesoid X receptor polymorphism predisposes to spontaneous bacterial peritonitis.
Lutz P; Berger C; Langhans B; Grünhage F; Appenrodt B; Nattermann J; Lammert F; Hoerauf A; Sauerbruch T; Strassburg CP; Spengler U; Nischalke HD
Dig Liver Dis; 2014 Nov; 46(11):1047-50. PubMed ID: 25086996
[TBL] [Abstract][Full Text] [Related]
12. [The INCA trial (impact of NOD2 genotype-guided antibiotic prevention on survival in patients with liver cirrhosis and ascites): precision medicine for patients with liver cirrhosis and ascites].
Casper M; Appenrodt B; Grünhage F; Lammert F
Z Gastroenterol; 2015 Nov; 53(11):1350-2. PubMed ID: 26562405
[No Abstract] [Full Text] [Related]
13. Analysis of monocyte chemotactic protein-1 gene polymorphism in patients with spontaneous bacterial peritonitis.
Gäbele E; Mühlbauer M; Paulo H; Johann M; Meltzer C; Leidl F; Wodarz N; Wiest R; Schölmerich J; Hellerbrand C
World J Gastroenterol; 2009 Nov; 15(44):5558-62. PubMed ID: 19938194
[TBL] [Abstract][Full Text] [Related]
14. Influence of genetic variations in the SOD1 gene on the development of ascites and spontaneous bacterial peritonitis in decompensated liver cirrhosis.
Schwab S; Lehmann J; Lutz P; Jansen C; Appenrodt B; Lammert F; Strassburg CP; Spengler U; Nischalke HD; Trebicka J
Eur J Gastroenterol Hepatol; 2017 Jul; 29(7):800-804. PubMed ID: 28403123
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-155 is upregulated in ascites in patients with spontaneous bacterial peritonitis.
Lutz P; M Haimid M; Pohlmann A; Lehmann J; Jansen C; Schierwagen R; Klein S; Strassburg CP; Spengler U; Trebicka J
Sci Rep; 2017 Jan; 7():40556. PubMed ID: 28074870
[TBL] [Abstract][Full Text] [Related]
16. Monocyte chemotactic protein-1 gene polymorphism and spontaneous bacterial peritonitis.
Filik L
World J Gastroenterol; 2010 Feb; 16(7):914. PubMed ID: 20143473
[TBL] [Abstract][Full Text] [Related]
17. Genetic variants of innate immunity receptors are associated with mortality in cirrhotic patients with bacterial infection.
Schaapman JJ; Amoros À; van der Reijden JJ; Laleman W; Zeuzem S; Bañares R; Jalan R; Arroyo V; Clària J; Verspaget HW; Coenraad MJ
Liver Int; 2020 Mar; 40(3):646-653. PubMed ID: 31991025
[TBL] [Abstract][Full Text] [Related]
18. Epistasis between Toll-like receptor-9 polymorphisms and variants in NOD2 and IL23R modulates susceptibility to Crohn's disease.
Török HP; Glas J; Endres I; Tonenchi L; Teshome MY; Wetzke M; Klein W; Lohse P; Ochsenkühn T; Folwaczny M; Göke B; Folwaczny C; Müller-Myhsok B; Brand S
Am J Gastroenterol; 2009 Jul; 104(7):1723-33. PubMed ID: 19455129
[TBL] [Abstract][Full Text] [Related]
19. Impact of NOD2 polymorphisms on infectious complications following chemotherapy in patients with acute myeloid leukaemia.
Yomade O; Spies-Weisshart B; Glaser A; Schnetzke U; Hochhaus A; Scholl S
Ann Hematol; 2013 Aug; 92(8):1071-7. PubMed ID: 23558906
[TBL] [Abstract][Full Text] [Related]
20. The INCA trial (Impact of NOD2 genotype-guided antibiotic prevention on survival in patients with liver Cirrhosis and Ascites): study protocol for a randomized controlled trial.
Casper M; Mengel M; Fuhrmann C; Herrmann E; Appenrodt B; Schiedermaier P; Reichert M; Bruns T; Engelmann C; Grünhage F; Lammert F;
Trials; 2015 Mar; 16():83. PubMed ID: 25887140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
